Our partner, and former president, Sergio Lavandero G. obtains the National Prize of Natural Sciences 2022

For his contributions in the research of chronic noncommunicable diseases

With a vast career in which his pioneering research related to cardiovascular diseases stands out, the Full Professor of the University of Chile, academic of the Faculty of Chemical and Pharmaceutical Sciences, and Adjunct Professor of the University of Texas Southwestern Medical Center, of the United States, was awarded this Monday, August 29, the recognition delivered by the Government of Chile.

Pharmaceutical Chemist and Doctor in Biochemistry from the University of Chile, the Professor of the Faculties of Chemical and Pharmaceutical Sciences and Medicine, Sergio Lavandero, was recognized on Monday, August 29, the National Prize for Natural Sciences 2022.

Professor Lavandero has outstanding research related to the discovery of new mechanisms in the development of cardiovascular diseases. Within his team, new ideas, mechanisms and cellular processes that occur in the genesis and development of cardiac pathologies have been described, as well as new potentials of therapeutic targets for their treatment.

"This award has a lot of meaning for me, particularly of gratitude to my University of Chile, because I could not be earning this award today if I did not recognize what it meant for my training, together with the National Institute. I am a child of public education and grateful for it. The University of Chile is wonderful, and above all it is wonderful when we come together to work together for great ideals, so I invite you to continue working for our University," said Professor Lavandero after receiving the recognition.

"The area in which I work is chronic non-communicable diseases, which are the pathologies that sicken and kill most Chileans and the population of the world, in order of importance, cardiovascular diseases, cancer, obesity and diabetes," said Lavandero, also highlighting the work of the Advanced Center for Chronic Diseases (ACCDiS) to train "new generations of scientists who do relevant research for the country."